Although AF10's target genes remain unknown, its implication in the development of myeloid, lymphoid and megakaryoblastic leukemia upon translocation with either MLL or CALM[16], [17] suggests that AF10 may be an important factor in the development of leukemia. This evidence concerns the gene KMT2A and leukemia.